Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease
- Resource Type
- Article
- Source
- In
Clinical Lymphoma Myeloma and Leukemia March 2018 18(3):204-209 - Subject
- Language
- ISSN
- 2152-2650